IL‐10 and TGF‐β1 have been reported to down‐regulate immune response in animal models of various diseases including inflammatory bowel disease, colitis, tumours and diabetes.1, 4, 5, 10. This evidence concerns the gene IL10 and inflammatory bowel disease.